International Journal of Clinical Pharmacy

, Volume 34, Issue 2, pp 272–276 | Cite as

Acceptance and importance of clinical pharmacists’ LIMM-based recommendations

  • Åsa Bondesson
  • Lydia Holmdahl
  • Patrik Midlöv
  • Peter Höglund
  • Emmy Andersson
  • Tommy Eriksson
Short Research Report

Abstract

Objective The objective of this study was to evaluate the quality of the clinical pharmacy service in a Swedish hospital according to the Lund Integrated Medicine Management (LIMM) model, in terms of the acceptance and clinical significance of the recommendations made by clinical pharmacists. Method The clinical significance of the recommendations made by clinical pharmacists was assessed for a random sample of inpatients receiving the clinical pharmacy service in 2007. Two independent physicians retrospectively ranked the recommendations emerging from errors in the patients’ current medication list and actual drug-related problems according to Hatoum, with rankings ranging between 1 (adverse significance) and 6 (extremely significant). Results The random sample comprised 132 patients (out of 800 receiving the service). The clinical significance of 197 recommendations was assessed. The physicians accepted and implemented 178 (90%) of the clinical pharmacists’ recommendations. Most of these recommendations, 170 (83%), were ranked 3 (somewhat significant) or higher. Conclusion This study provides further evidence of the quality of the LIMM model and confirms that the inclusion of clinical pharmacists in a multi-professional team can improve drug therapy for inpatients. The very high level of acceptance by the physicians of the pharmacists’ recommendations further demonstrates the effectiveness of the process.

Keywords

Clinical pharmacist Clinical significance Drug-related problems Hospital Medication reconciliation Medication review Sweden 

Notes

Acknowledgments

The assistance of Kristin Holmqvist and Nedal Ahmad, pharmacy students, who classified a large number of the drug-related problems and medication discrepancies, is acknowledged. Also, this study would not have been possible without the dedication and commitment of the ward staff.

Funding

None.

Conflicts of interest

The authors declare no conflicts of interest.

References

  1. 1.
    Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67(7):741–52. doi: 10.1007/s00228-010-0982-3.PubMedCrossRefGoogle Scholar
  2. 2.
    Scullin C, Scott MG, Hogg A, McElnay JC. An innovative approach to integrated medicines management. J Eval Clin Pract. 2007;13(5):781–8. doi: 10.1111/j.1365-2753.2006.00753.x.PubMedCrossRefGoogle Scholar
  3. 3.
    Hatoum HT, Hutchinson RA, Witte KW, Newby GP. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction. Drug Intell Clin Pharm. 1988;22:252–9.PubMedGoogle Scholar
  4. 4.
    Lee J, McPherson ML. Outcomes of recommendations by hospice pharmacists. Am J Health Syst Pharm. 2006;63:2235–9. doi: 10.2146/ajhp060143.PubMedCrossRefGoogle Scholar
  5. 5.
    Overhage JM, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities. Am J Health Syst Pharm. 1999;56:2444–50.PubMedGoogle Scholar
  6. 6.
    Bosma L, Jansman FG, Franken AM, Harting JW, Van den Bemt PM. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci. 2008;30:31–8. doi: 10.1007/s11096-007-9136-9.PubMedCrossRefGoogle Scholar
  7. 7.
    Sorensen L, Grobler MP, Roberts MS. Development of a quality use of medicines coding system to rate clinical pharmacists’ medication review recommendations. Pharm World Sci. 2003;25:212–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: The McGraw-Hill Companies Inc; 1998.Google Scholar
  9. 9.
    Chen TF, Neto A. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci. 2007;29:574–6. doi: 10.1007/s11096-007-9130-2.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Åsa Bondesson
    • 1
    • 2
    • 6
  • Lydia Holmdahl
    • 3
  • Patrik Midlöv
    • 4
  • Peter Höglund
    • 1
  • Emmy Andersson
    • 2
  • Tommy Eriksson
    • 5
    • 2
  1. 1.Department of Clinical PharmacologyLund UniversityLundSweden
  2. 2.Apoteket Farmaci AB, Hospital PharmacyLund University HospitalLundSweden
  3. 3.Department of MedicineLund University HospitalLundSweden
  4. 4.Department of Clinical Sciences in Malmoe, General Practice/Family MedicineLund UniversityLundSweden
  5. 5.Department of Clinical SciencesLund UniversityLundSweden
  6. 6.KristianstadSweden

Personalised recommendations